Skip to content

MiniMed Group MMED Work in process

Work in process at other companies

Griffon logo
GriffonGFF
$9.44M-24.6%
Kadant logo
KadantKAI
$51.76M+59.3%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$6.33M+709%
Wolfspeed logo
WolfspeedWOLF
$146.3M-51.9%
Ouster logo
OusterOUST
$1.57M+1,497%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$13.28M-2.4%

Other financials

Income statement

See full
Revenue$790.0M+15.0%
Gross profit$362.0M-8.4%
Operating income-$100.0M-576%
Net income-$119.0M-1,090%
EPS (diluted)-$0.47-1,075%

Balance sheet

See full
Cash & equivalents$10.0M0.0%
Total debt$61.0M
Total equity$3.5B-0.7%
Total assets$4.3B

Cash flow

See full
Operating cash flow-$27.0M-147%
CapEx$167.0M+22.8%
Free cash flow-$194.0M-146%

Valuation

See full
Market cap$3.86B

Returns & leverage

See full
Debt / equity
Current ratio1.6×

Where this comes from

Reported directly by MiniMed Group in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.

The official record: MiniMed Group ’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiniMed Group 's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiniMed Group 's work in process?
MiniMed Group (MMED) reported work in process of $44M in Q1 2026.
What does work in process mean?
Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.